| Business Summary | | CardioGenesis
Corporation,
formerly
Eclipse
Surgical
Technologies,
Inc.,
designs,
develops,
manufactures
and
distributes
laser-based
surgical
products
and
disposable
fiber-optic
accessories
for
the
treatment
of
advanced
cardiovascular
disease
through
transmyocardial
revascularization
(TMR)
and
percutaneous
transluminal
myocardial
revascularization
(PTMR).
TMR
and
PTMR
are
laser-based
heart
treatments
in
which
channels
are
made
in
the
heart
muscle.
TMR
is
performed
by
a
cardiac
surgeon
through
a
small
incision
in
the
chest
under
general
anesthesia.
PTMR
is
performed
by
a
cardiologist
in
a
catheter-based
procedure
that
utilizes
local
anesthesia.
Clinical
studies
have
demonstrated
a
significant
reduction
in
angina
and
increase
in
exercise
duration
in
patients
treated
with
TMR
or
PTMR
plus
medications,
when
compared
with
patients
who
received
medications
alone. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CardioGenesis
Corporation
designs,
develops,
manufactures
and
distributes
laser-based
surgical
products
and
disposable
fiber-optic
accessories
for
the
treatment
of
advanced
cardiovascular
disease.
For
the
six
months
ended
6/30/01,
revenues
fell
42%
to
$7.1
million.
Net
loss
fell
30%
to
$5.4
million.
Revenues
reflect
decreased
unit
sales
for
both
lasers
and
disposals.
Lower
loss
reflects
reduced
employee
related
expenses
and
decreased
physician
training
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Michael Quinn, 56 Chairman,
Pres, CEO | $81K | J. Stephen Wilkins, 47 CFO,
VP | -- | Ian Johnston, 46 VP-Fin.,
Treasurer | 137K | Darrell Eckstein, 43 VP-Operations | -- | Thomas Kinder, 38 VP
of Worldwide Sales | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|